Robin L. Kumoluyi

Robin L. Kumoluyi is Vice President and Chief Quality Officer, Johnson & Johnson, Pharmaceuticals. Robin also is a member of the Johnson & Johnson Quality and Compliance Leadership Team (QCLT), as well as the Pharmaceuticals Group Operating Committee (GOC).

In her current role, Robin leads the Pharmaceuticals QCLT in setting the quality and regulatory compliance strategy, leads the implementation of quality processes and systems, and develops talent to strengthen Johnson & Johnson’s quality and compliance profile and leadership position in the pharmaceutical industry.

Most recently as Vice President, Global Quality Systems (GQS), Robin implemented a new operating model that refined and focused the work of the enterprise team to better align with the businesses and gain efficiencies. She also defined and executed the strategic direction, development and oversight of the Q&C Strategy to prepare for our future innovative products and solutions while preserving our core foundation.

With more than 30 years of experience in quality and compliance and R&D, Robin brings a strong quality and technical skill set across a broad range of product categories to her new role. Prior to joining Johnson & Johnson in 2016, Robin served as the Vice President & Global Head, Third Party Operations Novartis Business Services, where she had global responsibility for the governance of the quality management of external supply partners across all Novartis divisions. Prior to Novartis, Robin held global roles with increasing levels of responsibilities within Q&C at Myogen, Schering-Plough and Warner Lambert/Pfizer. In addition, Robin gained Consumer experience from her tenure at The Coca Cola Corporation where she served as Director Global Quality Analytical Services.

Robin has been heavily involved in shaping the future within the pharmaceutical industry, participating in many industry working groups and forums, including the Consortium for Advanced Manufacturing of Pharmaceuticals (CAMP), PDA, DIA, ISPE, Rx360 and most recently, the Global Pharmaceutical Manufacturing Leadership Forum (GPMLF) where she is representing J&J in a working group focusing on the workforce of the future.

Robin holds a master’s degree in Quality Assurance/Regulatory Affairs from the School of Pharmacy at Temple University and a bachelor’s degree in Biological Sciences from Rutgers University.